..and that trials of angioplasty/stenting are justified in view of the biological plausibility of the concept.
Timothy Coetzee, chief research officer at the National Multiple Sclerosis Society, did not dismiss Marder's apparent debunking of the CCSVI theory completely, saying "In my mind the jury's still somewhat out on what it means for MS."
Another interventional neurologist agrees with Dr. Weir - Dr. Daniel Morales is treating patients for CCSVI at Hospital Angeles in Mexico, where experience with more than 400 patients has resulted in a treatment protocol that has excellent long term prognosis (reduced chance of restenosis). Learn more here and here.